MMP9 and prostate carcinoma: Compared with benign prostate tissue, higher NF-κB levels are detected in low- and high- grade prostate cancer specimens and are associated with the expression of NF-κB–regulated gene products including Bcl2, cyclinD1, MMP-9, and VEGF.